Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 3

Sponsor Class

INDUSTRY 3OTHER 1NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 17Thoracic 4Other solid neoplasm 3Tumor-Agnostic 2Head & Neck 1Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Advanced Malignant Solid Tumors 3

Interventions

Injections 98pembrolizumab 90Carboplatin 57Paclitaxel 54Cisplatin 52Nivolumab 44Docetaxel 43Pemetrexed 42Gemcitabine 37atezolizumab 32tislelizumab 29Bevacizumab 29toripalimab 23Fluorouracil 23Capecitabine 23Irinotecan 22Oxaliplatin 20durvalumab 19Ipilimumab 18Leucovorin 17Cetuximab 17Rifampin 14Itraconazole 14olaparib 13spartalizumab 12Midazolam 12Cyclophosphamide 12trifluridine tipiracil drug combination 11sintilimab 11Drug Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × neratinib × Other solid neoplasm × Clear all
NCT01128842 2018-12-19

A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid Tumor

Puma Biotechnology, Inc.

Phase 1 Completed
7 enrolled 13 charts
Other solid neoplasm

Advanced Malignant Solid Tumors

NCT00768469 2018-11-19

Study Evaluating Safety And Tolerability, Solid Tumor

Puma Biotechnology, Inc.

Phase 1 Completed
10 enrolled 11 charts
Other solid neoplasm

Advanced Malignant Solid Tumors

NCT00958724 2018-06-28

Study Evaluating Neratinib In Combination With Vinorelbine In Subjects With Advanced Or Metastatic Solid Tumors

Puma Biotechnology, Inc.

Phase 1 Completed
6 enrolled 13 charts
Other solid neoplasm

Advanced Malignant Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡